AGP Executive Report
Last update: 7 hours agoHemp Policy Fight: Congress is debating a nationwide ban on hemp-infused products, with Lancaster County businesses and farmers bracing for what it could mean for THC edibles and oils; Montana hemp processors also praised a U.S. Senate delay of a hemp ban, buying time for a longer-term fix. Medical Cannabis Research: New clinical reporting points to oral CBD helping with post-surgery ocular pain as effectively as opioids, while separate studies link medical cannabis to sustained improvements for endometriosis patients and reduced opioid use. Public Health Watch: The CDC is warning of a spike in emergency room visits tied to cannabis hyperemesis syndrome after a new diagnosis code, and UK reporting highlights fatal crashes involving cannabis edibles—fueling calls for tighter safety and education. Industry/Markets: Avicanna posted Q2 2026 results, highlighting growth in proprietary product sales and progress toward profitability. Legal/Enforcement: A drug dealer facing sentencing after a cannabis supply case and multiple international drug seizures keep the spotlight on enforcement pressure around cannabis and other drugs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.